Polisano Pharmaceuticals

Polisano Pharmaceuticals is a Romanian pharmaceutical company founded in 2003 as a greenfield investment in Sibiu, with 100% Romanian capital. Has invested over €70 million in state-of-the-art facilities and equipment. Holds GMP manufacturing authorisation and exports pharmaceutical products. In 2015 received ANMDM authorisation to conduct bioequivalence clinical studies, opening its own Bioequivalence Centre. Plans to build Romania's first oncology products factory in Sibiu. Acquired by the Grampet group in 2018.